Who are Epinephrine concentration of 1:1000000's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): IM epinephrine 1:1000, High-dose epinephrine, Ephedrine, bolus, Racemic adrenaline, Epinephrin 0.01, epinephrine perfusion.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/epinephrine-concentration-of-1-1000000.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Epinephrine concentration of 1:1000000 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epinephrine concentration of 1:1000000 (Epinephrine concentration of 1:1000000) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sympathomimetic amine / Adrenergic agonist. Area: Emergency Medicine / Cardiovascular / Anesthesia.

phase 3 Sympathomimetic amine / Adrenergic agonist Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors Emergency Medicine / Cardiovascular / Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Epinephrine concentration of 1:1000000 (Epinephrine concentration of 1:1000000) — Al-Azhar University. Epinephrine is an alpha and beta-adrenergic agonist that stimulates sympathetic nervous system receptors to increase heart rate, blood pressure, and bronchial airway diameter.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Epinephrine concentration of 1:1000000 TARGET	Epinephrine concentration of 1:1000000	Al-Azhar University	phase 3	Sympathomimetic amine / Adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
IM epinephrine 1:1000	IM epinephrine 1:1000	University of Louisville	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
High-dose epinephrine	High-dose epinephrine	Icahn School of Medicine at Mount Sinai	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Ephedrine, bolus	Ephedrine, bolus	University of Parma	marketed	Sympathomimetic amine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Racemic adrenaline	Racemic adrenaline	Oslo University Hospital	marketed	Sympathomimetic amine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Epinephrin 0.01	Epinephrin 0.01	Kasr El Aini Hospital	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
epinephrine perfusion	epinephrine perfusion	Central Hospital, Nancy, France	marketed	Sympathomimetic amine / Catecholamine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sympathomimetic amine / Adrenergic agonist class)

Al-Azhar University · 1 drug in this class
Amphastar Pharmaceuticals, Inc. · 1 drug in this class
Oman Medical Speciality Board · 1 drug in this class
University Health Network, Toronto · 1 drug in this class
University Hospital, Clermont-Ferrand · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Epinephrine concentration of 1:1000000 — Competitive Intelligence Brief. https://druglandscape.com/ci/epinephrine-concentration-of-1-1000000. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab